Durability of immune responses after boosting in Ad26.COV2.S-primed healthcare workers.
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Sablerolles, Roos S GRietdijk, Wim J R
Goorhuis, Abraham
Postma, Douwe F
Visser, Leo G
Schmitz, Katharina S
Geers, Daryl
Bogers, Susanne
van Haren, Eva
Koopmans, Marion P G
Dalm, Virgil A S H
Kootstra, Neeltje A
Huckriede, Anke L W
Akkerman, Renate
Beukema, Martin
Lafeber, Melvin
van Baarle, Debbie
de Vries, Rory D
van der Kuy, P Hugo M
GeurtsvanKessel, Corine H
Type
ArticleLanguage
en
Metadata
Show full item recordTitle
Durability of immune responses after boosting in Ad26.COV2.S-primed healthcare workers.Published in
Clinical infectious diseases 2022 Online ahead of printPMID
35723273ae974a485f413a2113503eed53cd6c53
10.1093/cid/ciac495
Scopus Count
Collections
Related articles
- Homologous Ad26.COV2.S vaccination results in reduced boosting of humoral responses in hybrid immunity, but elicits antibodies of similar magnitude regardless of prior infection.
- Authors: Moyo-Gwete T, Richardson SI, Keeton R, Hermanus T, Spencer H, Manamela NP, Ayres F, Makhado Z, Motlou T, Tincho MB, Benede N, Ngomti A, Baguma R, Chauke MV, Mennen M, Adriaanse M, Skelem S, Goga A, Garrett N, Bekker LG, Gray G, Ntusi NAB, Riou C, Burgers WA, Moore PL
- Issue date: 2023 Nov
- A homologous or variant booster vaccine after Ad26.COV2.S immunization enhances SARS-CoV-2-specific immune responses in rhesus macaques.
- Authors: He X, Aid M, Chandrashekar A, Yu J, McMahan K, Wegmann F, Jacob-Dolan C, Maron JS, Atyeo C, Wan H, Sellers D, Liu J, Lifton M, Gardner S, Bondzie EA, Barrett J, Ahmad K, Anioke T, Yalley-Ogunro J, Muench J, Goode A, Andersen H, Lewis MG, Alter G, Schuitemaker H, Zahn R, Barouch DH
- Issue date: 2022 Mar 30
- Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variant.
- Authors: Lyke KE, Atmar RL, Islas CD, Posavad CM, Szydlo D, Paul Chourdhury R, Deming ME, Eaton A, Jackson LA, Branche AR, El Sahly HM, Rostad CA, Martin JM, Johnston C, Rupp RE, Mulligan MJ, Brady RC, Frenck RW Jr, Bäcker M, Kottkamp AC, Babu TM, Rajakumar K, Edupuganti S, Dobrzynski D, Coler RN, Archer JI, Crandon S, Zemanek JA, Brown ER, Neuzil KM, Stephens DS, Post DJ, Nayak SU, Suthar MS, Roberts PC, Beigel JH, Montefiori DC, DMID 21-0012 Study Group
- Issue date: 2022 Jul 19
- Humoral and cellular immunogenicity of homologous and heterologous booster vaccination in Ad26.COV2.S-primed individuals: Comparison by breakthrough infection.
- Authors: Hyun H, Jang AY, Park H, Heo JY, Seo YB, Nham E, Yoon JG, Seong H, Noh JY, Cheong HJ, Kim WJ, Yoon SY, Seok JH, Kim J, Park MS, Song JY
- Issue date: 2023
- Booster with Ad26.COV2.S or Omicron-adapted vaccine enhanced immunity and efficacy against SARS-CoV-2 Omicron in macaques.
- Authors: Solforosi L, Costes LMM, Tolboom JTBM, McMahan K, Anioke T, Hope D, Murdza T, Sciacca M, Bouffard E, Barrett J, Wu C, Hachmann N, Miller J, Yu J, He X, Jacob-Dolan C, Huber SKR, Dekking L, Chamanza R, Choi Y, Boer KF, Barouch DH, Schuitemaker H, Zahn RC, Wegmann F
- Issue date: 2023 Apr 7